ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $408,000 | +1600.0% | 590,846 | +1192.9% | 0.00% | – |
| Q3 2020 | $24,000 | -97.5% | 45,700 | -96.5% | 0.00% | – |
| Q2 2020 | $955,000 | -38.8% | 1,300,052 | -22.3% | 0.00% | – |
| Q1 2020 | $1,560,000 | +590.3% | 1,672,218 | +1406.5% | 0.00% | – |
| Q4 2019 | $226,000 | -44.5% | 111,000 | -21.8% | 0.00% | – |
| Q3 2019 | $407,000 | -89.4% | 141,873 | -71.7% | 0.00% | – |
| Q2 2019 | $3,850,000 | +59.2% | 501,602 | +175.8% | 0.00% | -100.0% |
| Q1 2019 | $2,418,000 | -29.3% | 181,900 | -17.1% | 0.00% | 0.0% |
| Q4 2018 | $3,419,000 | -57.0% | 219,466 | -45.8% | 0.00% | -50.0% |
| Q3 2018 | $7,957,000 | -34.3% | 404,904 | -4.1% | 0.00% | -50.0% |
| Q2 2018 | $12,120,000 | -2.4% | 422,300 | -19.6% | 0.00% | 0.0% |
| Q1 2018 | $12,423,000 | +123.0% | 525,300 | +102.2% | 0.00% | +100.0% |
| Q4 2017 | $5,572,000 | -25.0% | 259,800 | -17.3% | 0.00% | -33.3% |
| Q3 2017 | $7,426,000 | +54.4% | 314,000 | +28.6% | 0.00% | 0.0% |
| Q2 2017 | $4,811,000 | -82.7% | 244,200 | -81.6% | 0.00% | -78.6% |
| Q1 2017 | $27,840,000 | +116.1% | 1,325,700 | +93.4% | 0.01% | +100.0% |
| Q4 2016 | $12,884,000 | -2.2% | 685,331 | +8.6% | 0.01% | +16.7% |
| Q3 2016 | $13,179,000 | +349.8% | 631,200 | +449.3% | 0.01% | +200.0% |
| Q2 2016 | $2,930,000 | -37.2% | 114,900 | -34.8% | 0.00% | -33.3% |
| Q1 2016 | $4,663,000 | +119.7% | 176,295 | +255.4% | 0.00% | +200.0% |
| Q4 2015 | $2,122,000 | -10.1% | 49,601 | -44.3% | 0.00% | – |
| Q3 2015 | $2,360,000 | +31.6% | 88,988 | +65.4% | 0.00% | – |
| Q2 2015 | $1,793,000 | -75.0% | 53,796 | -75.0% | 0.00% | -100.0% |
| Q1 2015 | $7,175,000 | -25.2% | 215,567 | -8.1% | 0.00% | +33.3% |
| Q4 2014 | $9,589,000 | +3.5% | 234,610 | -14.2% | 0.00% | -25.0% |
| Q3 2014 | $9,261,000 | +73.3% | 273,363 | +72.5% | 0.00% | +100.0% |
| Q2 2014 | $5,343,000 | +0.1% | 158,481 | +12.6% | 0.00% | -33.3% |
| Q1 2014 | $5,337,000 | +133.9% | 140,759 | +80.2% | 0.00% | +200.0% |
| Q4 2013 | $2,282,000 | +3.2% | 78,128 | +21.1% | 0.00% | 0.0% |
| Q3 2013 | $2,211,000 | -32.1% | 64,504 | -34.6% | 0.00% | 0.0% |
| Q2 2013 | $3,256,000 | – | 98,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |